Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables

OBJECTIVE: To propose appropriate statements that drive the choice of biologic therapies in patients with rheumatoid arthritis (RA), factoring in their impact on the following issues: anti-drug antibody (ADAb) formation, suspicion and management of infections, lupus-like syndrome (LLS), effects on b...

Descripción completa

Detalles Bibliográficos
Autores principales: Niccoli, Laura, Nannini, Carlotta, Blandizzi, Corrado, Mantarro, Stefania, Mosca, Marta, Di Munno, Ombretta, Goletti, Delia, Benucci, Maurizio, Gobbi, Francesca Li, Cassarà, Emanuele, Kaloudi, Olga, Cantini, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207089/
https://www.ncbi.nlm.nih.gov/pubmed/30498353
http://dx.doi.org/10.2147/TCRM.S175772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207089/
https://www.ncbi.nlm.nih.gov/pubmed/30498353
http://dx.doi.org/10.2147/TCRM.S175772

Ejemplares similares